Regulation of Microphage Migration Inhibitory Factor (MIF) Activity

a technology activity regulation, which is applied in the field of modulating, neutralizing, or inactivating the activity of migration inhibitory factor (mif), and can solve problems such as unwanted side effects and complications

Inactive Publication Date: 2009-11-05
THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0010]Applicant has discovered that 1) MIF dos not exist by itself as an individual protein in urine, blood, or tissues; 2) MIF is associated with acute phase proteins in vivo; 3) the association of MIF with t

Problems solved by technology

These patents use compounds that are not normally associated with MIF, thus, may result in unwanted side effects and complications when used in vivo.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
  • Regulation of Microphage Migration Inhibitory Factor (MIF) Activity
  • Regulation of Microphage Migration Inhibitory Factor (MIF) Activity

Examples

Experimental program
Comparison scheme
Effect test

example 1

MIF is Only Found Complexed With Other Proteins in vivo

[0041]In order to establish the form of MIF found in tissues and the changes associated with treatments designed to induce neurogenic inflammation; rat intraluminal fluid was analyzed for MIF using ELISA (Table 1). As reported previously, substance P (SP) treatment induced a significant increase in intraluminal MIF amounts (Table 1). Intravesical capsaicin resulted in a dose-dependent excretion of MIF into the intraluminal fluid (Table 1).

TABLE 1Changes in intraluminal MIF concentrationsInflammatory inducerIntraluminal MIF (ng / mL)ControlTreatment(n = 5)(n = 5)Substance P1.8 ± 0.79.5 ± 1.0***(subcutaneous)Control0.1 mM1.0 mM(n = 3)(n = 3)(n = 3)Capsaicin4.1 ± 0.613.9 ± 3.228.6 ± 3.8**(intravesical)Intraluminal MIF amounts were determined using a rat MIF specific ELISA. Data are expressed as mean MIF ng / mL of intraluminal fluid ± S.E.M.,**= p ***= p

[0042]Rat urine, intraluminal fluid and bladder tissue were also analyzed by nativ...

example 2

Identification of MIF Associated Proteins as Alpha-1-Inhibitor-3

Mass Spectroscopy

[0046]Duplicate samples of intraluminal fluid were separated by non-reducing NuPAGE electrophoresis with one sample analyzed by Western blotting and its duplicate Coomassie stained. X-ray film of the Western blot was used to identify MIF complex Coomassie stained bands for mass spectroscopy analysis (protein Chemistry Core Laboratory; University of Florida, Gainesville, Fla.). These bands were identified as several acute phase proteins (Table 2). The highest and most significant match (for either the 170 or 130 kDa band) was alpha-1-inhibitor-3 (α-1-I-3), however, peptides matching alpha-2-macroglobulin, complement component 4, and ceruloplasmin precursor were also identified.

TABLE 2Proteins identified by mass spectroscopyReferencePeptidesBandNumberProtein (molecular weight)ScoreMatched170 kDagi|12831225α(1)-inhibitor 3 (166 kDa)50120gi|112893α(1)-inhibitor 3 precursor (165 kDa)48717gi|109550α-2-macrog...

example 3

MIF Complexes in Human Urine

Bacterial Cystitis Induced MIF Complexes

[0048]MIF western blot (WB) of urine proteins from UTI patients separated under native conditions resulted in a prominent high molecular weight band in the range of 150 to 500 kDa (FIG. 6). A less intense band at the same molecular weight range was observed in WB of urine from non-UTI patients. Under native WB conditions, a 12 kDa band indicative of monomeric MIF was not detected (FIG. 6). However, under denaturing conditions, WB of the same sample resulted in three prominent high molecular weight bands of 165, 135 and 100 kDa as well as the 12 kDa monomeric MIF band (FIG. 6). MIF staining intensity was greater in the samples from UTI patients. Under reducing conditions only a single MIF staining band at 12 kDa was evident in all the urine samples. The MIF band staining intensity was greatest in urine from UTI patients (FIG. 6).

[0049]Thus, in agreement with Examples 1-2, MIF in human urine is found in high molecular...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Massaaaaaaaaaa
Massaaaaaaaaaa
Massaaaaaaaaaa
Login to View More

Abstract

The present invention relates to modulating, neutralizing, or inactivating the activity of migration inhibitory factor (MIF). In particularm, the present invention provides methods for modulating, neutralizing, or inactivating MIF activity by complexing MIF with other molecules, preferably a protein, that is capable of associating with MIF. These molecules can be used for treating diseases by the regulation of MIF activity.

Description

[0001]This application claims priority to U.S. Provisional Patent Application No. 60 / 640,170, filed Dec. 30, 2004, which is incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates to modulating, neutralizing, or inactivating the activity of migration inhibitory factor (MIF). In particular, the present invention relates to methods of treating inflammatory diseases by the regulation of MIF activity.BACKGROUND[0003]MIF was first described thirty years ago and was designated as a cytokine, a chemical mediator, which regulates cell growth by inducing the expression of specific target genes. The initial described function of MIF was as a regulator of inflammation and immunity. It is expressed in the brain, and eye lens, is a delayed early response gene in fibroblasts, and it has been reported that this protein can be found in prostate tissues. MIF has been shown to be a pituitary, as well as macrophage cytokine and a critical mediator of septic shock. Re...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/10G01N33/566G01N33/68A61K38/17A61K38/08C07K14/47A61P35/00
CPCA61K38/1709A61K38/57G01N2500/02G01N33/6863C07K14/52A61P35/00
InventorMEYER-SIEGLER, KATHERINEVERA, PEDRO
OwnerTHE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS